Aktie A2QMMF ENVIRONMENTAL IMPACT ACQUISITION CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Environmental Impact Acquisition Corp. Nasdaq

Aktien

A2QMMF

US29408N2053

ENVIU

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
GreenLight Biosciences Completes Going Private Transaction
GreenLight Biosciences Agrees to be Acquired by Fall Line Capital-Led Group in $45.5 Million Deal
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Reports Q1 Revenue $3.8M
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
GreenLight Biosciences Releases Inaugural Sustainability Report
GreenLight Biosciences Gets Interest Indication From Fall Line Endurance Fund; Shares Rise After-Hours
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Greenlight Biosciences Q4 EPS Loss Narrow, Revenue Rises
GREENLIGHT BIOSCIENCES HOLDINGS, PBC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Reports Q4 Revenue $3M
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
GreenLight Biosciences Secures Rwanda FDA Approval for COVID-19 Clinical Trial
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
GreenLight Biosciences, Epivax Therapeutics to Jointly Develop Personalized Cancer Vaccines
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DD3F Aktie
  4. A2QMMF Aktie
  5. Nachrichten Environmental Impact Acquisition Corp.
  6. Andere Sprachen